Bivalent group A and C meningococcal vaccine (Menomune-A/C) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

a+c meningococcal polysaccharide vaccine | group a, c polysaccharide meningococcal vaccine | mcv-ac vaccine group | menac | meningococcal a&c vaccine | meningococcal a+c vaccine

Organizations (19)

Research & Development (19)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (22)

Approved Indications (1)


 

Meningitis, Meningococcal (approved 1978)

Experimental Indications - Clinical Trial Phases 1-4 (22)


 

Dengue (Phase 3)

Dengue Virus (Phase 2)

Dermatitis, Atopic (Phase 2)

Diphtheria (Phase 3)

Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)

Haemophilus influenzae type b (Phase 3)

Hand, Foot and Mouth Disease (Phase 4)

Healthy Volunteers (Phase 1)

Hepatitis B (Phase 3)

Influenza B virus (Phase 3)

Influenza, Human (Phase 3)

Meningitis (Phase 4)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 4)

Pertussis Vaccine (Phase 3)

Poliomyelitis (Phase 3)

Rabies (Phase 3)

Severe Dengue (Phase 3)

Tetanus (Phase 3)

Typhoid Fever (Phase 4)

Vaccines (Phase 3)

Yellow Fever (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial Organizations: 19

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue